The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

by Berg Thomas, Däumer Martin, Tappe André, Stürmer Martin, Kaiser Rolf, Walter Hauke, Ehret Robert, Vachta Jan, Wiesmann Frank, Naeth Gudrun, Braun Patrick, Knechten Heribert
Published 2011-02-01